Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Use of vitamins for correction of the functional state of cytochrome P450 systems at experimental allergic encephalomyelitis].
T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
T Cell Epitope Redundancy: Cross-conservation of the TCR face between Pathogens and Self and its Implications for Vaccines and Auto-immunity.
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis.
Multiple Sclerosis: Progress, but No Cure.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Differential diagnosis and prognosis for longitudinally extensive myelitis in Buenos Aires, Argentina.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
[Neurological complications during treatment of the tumor necrosis alpha inhibitors].
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Cutting-edge of advanced MRI for demyelinating diseases.
Lentivirus-Mediated RNA Interference Targeting RhoA Slacks the Migration, Proliferation, and Myelin Formation of Schwann Cells.
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.

Pages